rs666553
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs666553(C;C) |
Make rs666553(C;T) |
Make rs666553(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 11 |
Position | 101067937 |
Gene | PGR |
is a | snp |
is | mentioned by |
dbSNP | rs666553 |
dbSNP (classic) | rs666553 |
ClinGen | rs666553 |
ebi | rs666553 |
HLI | rs666553 |
Exac | rs666553 |
Gnomad | rs666553 |
Varsome | rs666553 |
LitVar | rs666553 |
Map | rs666553 |
PheGenI | rs666553 |
Biobank | rs666553 |
1000 genomes | rs666553 |
hgdp | rs666553 |
ensembl | rs666553 |
geneview | rs666553 |
scholar | rs666553 |
rs666553 | |
pharmgkb | rs666553 |
gwascentral | rs666553 |
openSNP | rs666553 |
23andMe | rs666553 |
SNPshot | rs666553 |
SNPdbe | rs666553 |
MSV3d | rs666553 |
GWAS Ctlg | rs666553 |
GMAF | 0.1786 |
Max Magnitude | 0 |
? | (C;C) (C;T) (T;T) | 28 |
---|---|---|
|
news The effectiveness of 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth is influenced by SNPs.
Black women
- rs471767 homozygous for the major allele treatment significantly reduced the rate of preterm birth.
- rs578029 who had a least one copy of the major allele, treatment significantly reduced in preterm birth
non-black women
- a least one copy of the minor allele of rs503362 had a significant reduction with treatment
- with at least one copy of the minor allele of rs666553 had a significant reduction in very preterm birth
[PMID 21600550] Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate